Shiwei He

机构：Changchun University of Science and Technology, Hebei Medical University, Fujian Medical University, Sun Yat-sen University, Sichuan Agricultural University, Guangxi Academy of Special Crops, Key Laboratory of Guangdong Province, Medical Center Hospital, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Changchun University, Anhui University of Technology · ORCID：0000-0002-1590-0656

发表论文 70 篇 · 总被引 1574 次 · h-index 21

代表论文

• Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways (2024 · Experimental Hematology and Oncology · 被引 35)
• PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma (2024 · Nature Communications · 被引 32)
• Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4/ITGA6 translation (2024 · Oncogene · 被引 22)
• DNAJA4 suppresses epithelial-mesenchymal transition and metastasis in nasopharyngeal carcinoma via PSMD2-mediated MYH9 degradation (2023 · Cell Death and Disease · 被引 21)
• LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein (2024 · Drug Resistance Updates · 被引 18)
• The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma (2024 · Neuro-Oncology · 被引 13)